Is Amazon an AI Stock?
With the market starting to look skittish on pure-play AI…
Buy
60
MRM Quote, Financials, Valuation and Earnings
Last price:
$2.13
Seasonality move
:
-9.45%
Day range:
$2.03 - $2.15
52-week range:
$0.34 - $4.45
Dividend yield:
0%
P/E ratio:
5.83x
P/S ratio:
0.26x
P/B ratio:
2.91x
Volume:
757.7K
Avg. volume:
314.9K
1-year change:
-31.35%
Market cap:
$16.9M
Revenue:
$54.8M
EPS (TTM):
-$0.12
Analysts' Opinion
-
Consensus RatingMEDIROM Healthcare Technologies, Inc. has received a consensus rating of Buy. The company's average rating is a Buy based on 1 Buy rating, 0 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $4.98, MEDIROM Healthcare Technologies, Inc. has an estimated upside of 132.99% from its current price of $2.14.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $4.98 representing 100% downside risk from its current price of $2.14.
Fair Value
-
According to the consensus of 1 analyst, MEDIROM Healthcare Technologies, Inc. has 132.99% upside to fair value with a price target of $4.98 per share.
MRM vs. S&P 500
-
Over the past 5 trading days, MEDIROM Healthcare Technologies, Inc. has overperformed the S&P 500 by 6.89% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
MEDIROM Healthcare Technologies, Inc. does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
MEDIROM Healthcare Technologies, Inc. has grown year-over-year revenues for 0 quarters straight. In the most recent quarter MEDIROM Healthcare Technologies, Inc. reported revenues of --.
Earnings Growth
-
MEDIROM Healthcare Technologies, Inc. has grown year-over-year earnings for 0 quarters straight. In the most recent quarter MEDIROM Healthcare Technologies, Inc. reported earnings per share of --.
Enterprise value:
28.7M
EV / Invested capital:
--
Price / LTM sales:
0.26x
EV / EBIT:
39.99x
EV / Revenue:
0.53x
PEG ratio (5yr expected):
0.54x
EV / Free cash flow:
-2.34x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
11.09x
Gross Profit (TTM):
$10.2M
Return On Assets:
-1.31%
Net Income Margin (TTM):
-1.17%
Return On Equity:
--
Return On Invested Capital:
-6.44%
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-12-05 | 2024-12-05 | 2024-12-05 | |||
| Income Statement | ||||||
| Revenue | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| Diluted EPS | -- | -- | -- | -- | -- | |
| Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $7.9M | $9M | $10.8M | $6.9M | -- | |
| Total Assets | $47M | $40.2M | $41.8M | $36.2M | -- | |
| Current Liabilities | $22.1M | $23.2M | $22.6M | $20.5M | -- | |
| Total Liabilities | $45.2M | $43M | $44.7M | $38.5M | -- | |
| Total Equity | $1.9M | -$2.9M | -$2.9M | -$2.3M | -- | |
| Total Debt | $6.8M | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-12-05 | 2024-12-05 | 2024-12-05 | |||
| Cash Flow Statement | ||||||
| Cash Flow Operations | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Free Cash Flow | -- | -- | -- | -- | -- | |
MRM
Sector
Market Cap
$16.9M
$324.5M
Price % of 52-Week High
47.98%
73.51%
Dividend Yield
0%
0%
Shareholder Yield
--
2.01%
1-Year Price Total Return
-31.35%
-6.69%
Beta (5-Year)
--
0.547
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$2.03
200-day SMA
Buy
Level
$1.46
Bollinger Bands (100)
Buy
Level
1.53 - 2.31
Chaikin Money Flow
Sell
Level
-11.4M
20-day SMA
Buy
Level
$2.03
Relative Strength Index (RSI14)
Buy
Level
54.09
ADX Line
Buy
Level
10.57
Williams %R
Sell
Level
-6.25
50-day SMA
Sell
Level
$2.15
MACD (12, 26)
Buy
Level
0.03
25-day Aroon Oscillator
Sell
Level
-12
On Balance Volume
Neutral
Level
40.7M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (0.9173)
Sell
CA Score
(Annual)
Level (-2.0162)
Sell
Beneish M-Score
(Annual)
Level (-0.8812)
Buy
Momentum Score
Level (5)
Sell
Ohlson Score
Level (4.2209)
Buy
Piotroski F Score
(Annual)
Level (7)
--
Quality Ratio Score
Level (--)
--
Fundamental Score
Level (--)
Revenue Forecast
Earnings per Share Forecast
Company Profile
MEDIROM Healthcare Technologies, Inc. owns, develops, operates, manages, and supports relaxation salons through the franchising and direct ownership of such salons. It provides relaxation and bodywork services. The firm operates two synergistic lines of businesses: Relaxation Salon Segment (retail) and Digital Preventative Healthcare Segment (healthtech). The company was founded by Kouji Eguchi on July 13, 2000 and is headquartered in Tokyo, Japan.
Stock Forecast FAQ
In the current month, MRM has received 1 Buy ratings 0 Hold ratings, and 0 Sell ratings. The MRM average analyst price target in the past 3 months is $4.98.
-
Where Will MEDIROM Healthcare Technologies, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that MEDIROM Healthcare Technologies, Inc. share price will rise to $4.98 per share over the next 12 months.
-
What Do Analysts Say About MEDIROM Healthcare Technologies, Inc.?
Analysts are divided on their view about MEDIROM Healthcare Technologies, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that MEDIROM Healthcare Technologies, Inc. is a Sell and believe this share price will drop from its current level to $4.98.
-
What Is MEDIROM Healthcare Technologies, Inc.'s Price Target?
The price target for MEDIROM Healthcare Technologies, Inc. over the next 1-year time period is forecast to be $4.98 according to 1 Wall Street analyst, 1 of them rates the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is MRM A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for MEDIROM Healthcare Technologies, Inc. is a Buy. 1 of 1 analysts rates the stock a Buy at this time.
-
How Can I Buy Shares Of MRM?
You can purchase shares of MEDIROM Healthcare Technologies, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase MEDIROM Healthcare Technologies, Inc. shares.
-
What Is The MEDIROM Healthcare Technologies, Inc. Share Price Today?
MEDIROM Healthcare Technologies, Inc. was last trading at $2.13 per share. This represents the most recent stock quote for MEDIROM Healthcare Technologies, Inc.. Yesterday, MEDIROM Healthcare Technologies, Inc. closed at $2.14 per share.
-
How To Buy MEDIROM Healthcare Technologies, Inc. Stock Online?
In order to purchase MEDIROM Healthcare Technologies, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get MRM Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
MRM
Sector
P/E ratio
5.83x
17.35x
PEG ratio
0.54x
0.12x
P/B ratio
2.91x
1.35x
Price / LTM sales
0.26x
0.59x
Growth Metrics
MRM
Sector
Revenue growth
--
3.41%
Earnings growth
--
--
Revenue (5-year growth)
8.85%
3.17%
Earnings forecast
--
$0.26
Profitability
MRM
Sector
Profitability FY 2024
$14.8M
$300.9M
Return on invested capital
-6.44%
3.41%
Return on assets
-1.31%
2.29%
Return on equity
--
5.95%
Earnings Date
Last Earnings Date
Nov
7
Next Earnings Date
Dec
5
Estimated Next Earnings Date
Mar
6
Balance Sheet
MRM
Sector
Total cash
$898.8K
$137M
Short term investments
$39.2K
$41.4M
Total assets
$56.9M
$1.2B
Long term debt
$10M
$42.6M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Google Vs NVIDIA Stock: Which Is Best?
Alphabet (NASDAQ:GOOGL) and NVIDIA (NASDAQ:NVIDIA) are two of the market’s…
How High Could NVIDIA Stock Go?
NVIDIA (NASDAQ:NVDA) has been one of the best stocks to…
Stock Ideas
Buy
52
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 62x
Buy
61
Is AAPL Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 38x
Buy
63
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 40x
Alerts
Buy
54
SMX alert for Dec 5
SMX (Security Matters) Plc [SMX] is up 154.74% over the past day.
Sell
15
HOV alert for Dec 5
Hovnanian Enterprises, Inc. [HOV] is down 22.58% over the past day.
Buy
67
NUTX alert for Dec 5
Nutex Health, Inc. [NUTX] is up 18.9% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
